Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Botulinum toxin is effective for various skin conditions, but more research and awareness of side effects are needed.

Combining Endo-RF with PRP may improve acne scars better than Endo-RF alone.

PRP treatment may help with alopecia areata, especially in newer cases.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Almost 40% of women aged 20-70 in Isfahan had hair loss, with it being more severe in those with low ferritin levels.

Phototherapy effectively treats certain alopecia areata types, especially if started early.

Inclusive dermatology aims to provide personalized skin care for all by addressing diverse needs and disparities.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Severe and early hair loss may indicate a higher risk of heart disease.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Male pattern baldness doesn't significantly affect mental health or sexual well-being.

Finasteride reduced seizures and prevented cognitive issues in rats after neonatal asphyxia but increased anxiety later.

Alopecia areata patients are more likely to develop systemic lupus erythematosus.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

Stem cell treatment improved life quality and sexual function in women with hair loss.